De novo mutation of Charcot-Marie-Tooth disease type 1A

Pediatr Neurol. 1997 Jul;17(1):67-9. doi: 10.1016/s0887-8994(97)80670-4.

Abstract

Charcot-Marie-Tooth disease type 1A (CMT 1A) is an autosomal dominant demyelinating polyneuropathy associated with a 1.5-Mb duplication of the p11.2-p12 region of chromosome 17, including the peripheral myelin protein-22 (PMP-22) gene (CMT 1A duplication). We report a male patient with a de novo CMT 1A diagnosed on clinical, electrophysiologic, and molecular grounds. Motor nerve conduction velocity (MCV) of the patient was 10.9 m/s in the ulnar nerve. The MCV of both his parents was within the normal range. Southern blot analysis of BamHI digestion showed reduced intensity rate of SF85/PMP-22, indicating CMT 1A duplication. Haplotype analysis with pVAW4093a, demonstrated that the de novo CMT 1A duplication was of paternal origin.

Publication types

  • Case Reports

MeSH terms

  • Blotting, Southern
  • Charcot-Marie-Tooth Disease / genetics*
  • Chromosome Aberrations / genetics
  • Chromosome Disorders
  • Chromosomes, Human, Pair 17*
  • DNA Mutational Analysis
  • Genes, Dominant / genetics
  • Genetic Carrier Screening
  • Humans
  • Infant
  • Male
  • Mutation*
  • Myelin Proteins / genetics
  • Pedigree

Substances

  • Myelin Proteins
  • PMP22 protein, human